Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

West Pharmaceutical Introduces New Analytical Services Capabilities

By Mike Botta | May 18, 2018

West Pharmaceutical Services, Inc. has expanded its analytical services capabilities to address challenges concerning packaging, delivery, and combination product needs. The new capabilities include the addition of technical experts in several focus areas, equipment, and new technology to help navigate ever-changing global regulatory and quality demands.

“To ensure that therapies are coming to market safely and effectively, it’s critical that our customers have the needed data and insights to thoroughly examine the compatibility between a therapy and its primary containment and delivery technology to mitigate potential risk to patients and help them move more easily through development,” said Jennifer L. Riter, senior director of analytical services at West Pharmaceutical.

An example of some of the newer equipment is an ion mobility quadrupole time of flight mass spectrometer (Q-ToF), which allows for both separation and selectivity by combining chromatography, ion mobility, and, mass spectrometry for enhanced extractable and leachable analysis. In addition, a new oxygen headspace analyzer was acquired to address Container Closure Integrity (CCI) needs with several packaging and delivery systems.

The company also incorporated ISO performance testing methodologies to assist clients in qualifying and evaluating their drug products with various packaging, delivery, and combination products as they transition from molecule to market.

West reports that its analytical services labs are GMP and FDA compliant, DEA licensed, certified to ISO 9001:2008 and ISO 15378:2011, and have two MHRA certificates.

(Source: West Pharmaceutical Services, Inc.)

Related Articles Read More >

Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Prolific Machines logo.
Prolific Machines enters FDA program to enhance therapeutics manufacturing platform
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE